{"id":386217,"date":"2020-12-23T00:00:00","date_gmt":"2020-12-23T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ur0054-medtech-urological-devices-market-insights-europe-supplemental-2021\/"},"modified":"2026-04-14T10:05:31","modified_gmt":"2026-04-14T10:05:31","slug":"m360ur0054-medtech-urological-devices-market-insights-europe-supplemental-2021","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ur0054-medtech-urological-devices-market-insights-europe-supplemental-2021\/","title":{"rendered":"Urological Devices | Market Insights | Europe (Supplemental) | 2021"},"content":{"rendered":"<p>Driven by product innovation and an aging population, the European urological device market will grow at a\u00a0modest rate\u00a0through 2029 despite the impact of the ongoing\u00a0COVID-19\u00a0pandemic. Revenue growth will be driven by ongoing product innovation and an increasing aging population and an associated rise in cases of urological\u00a0diseases such as\u00a0UI, stones,\u00a0BPH, prostate and bladder cancer, and\u00a0ED; however, limited capital equipment budgets among European health care facilities and prevailing preferences for established treatment methods will hinder the adoption of newer, premium-priced technology to some degree, hampering overall market growth.<\/p>\n<p>This Medtech 360 Report\u00a0provides high-level market metrics for urological devices in\u00a0Europe, including country-level data for major countries and aggregate data for the rest of Europe,\u00a0across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386217","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-urological-devices","medtech-therapy-area-urology","medtech-geography-europe","medtech-date-945"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386217\/revisions"}],"predecessor-version":[{"id":387727,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386217\/revisions\/387727"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}